Development and Validation of a Machine Learning Model for Early Detection of Untreated Infection
- PMID: 39392375
- PMCID: PMC11473064
- DOI: 10.1097/CCE.0000000000001165
Development and Validation of a Machine Learning Model for Early Detection of Untreated Infection
Abstract
Background: Early diagnostic uncertainty for infection causes delays in antibiotic administration in infected patients and unnecessary antibiotic administration in noninfected patients.
Objective: To develop a machine learning model for the early detection of untreated infection (eDENTIFI), with the presence of infection determined by clinician chart review.
Derivation cohort: Three thousand three hundred fifty-seven adult patients hospitalized between 2006 and 2018 at two health systems in Illinois, United States.
Validation cohort: We validated in 1632 patients in a third Illinois health system using area under the receiver operating characteristic curve (AUC).
Prediction model: Using a longitudinal discrete-time format, we trained a gradient boosted machine model to predict untreated infection in the next 6 hours using routinely available patient demographics, vital signs, and laboratory results.
Results: eDENTIFI had an AUC of 0.80 (95% CI, 0.79-0.81) in the validation cohort and outperformed the systemic inflammatory response syndrome criteria with an AUC of 0.64 (95% CI, 0.64-0.65; p < 0.001). The most important features were body mass index, age, temperature, and heart rate. Using a threshold with a 47.6% sensitivity, eDENTIFI detected infection a median 2.0 hours (interquartile range, 0.9-5.2 hr) before antimicrobial administration, with a negative predictive value of 93.6%. Antibiotic administration guided by eDENTIFI could have decreased unnecessary IV antibiotic administration in noninfected patients by 10.8% absolute or 46.4% relative percentage points compared with clinicians.
Conclusion: eDENTIFI could both decrease the time to antimicrobial administration in infected patients and unnecessary antibiotic administration in noninfected patients. Further prospective validation is needed.
Copyright © 2024 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the Society of Critical Care Medicine.
Conflict of interest statement
Dr. Buell is supported by T32 HL007605. Dr. Bhavani is supported by the National Institute of General Medical Sciences GM144867. Dr. Parker is supported by K08HL150291 and R01LM014263. Dr. Churpek is supported by R35GM145330. The remaining authors have disclosed that they do not have any potential conflicts of interest.
Figures


Similar articles
-
Machine Learning to Predict Mortality and Critical Events in a Cohort of Patients With COVID-19 in New York City: Model Development and Validation.J Med Internet Res. 2020 Nov 6;22(11):e24018. doi: 10.2196/24018. J Med Internet Res. 2020. PMID: 33027032 Free PMC article.
-
Investigating the Impact of Different Suspicion of Infection Criteria on the Accuracy of Quick Sepsis-Related Organ Failure Assessment, Systemic Inflammatory Response Syndrome, and Early Warning Scores.Crit Care Med. 2017 Nov;45(11):1805-1812. doi: 10.1097/CCM.0000000000002648. Crit Care Med. 2017. PMID: 28737573 Free PMC article.
-
Predicting Intensive Care Unit Readmission with Machine Learning Using Electronic Health Record Data.Ann Am Thorac Soc. 2018 Jul;15(7):846-853. doi: 10.1513/AnnalsATS.201710-787OC. Ann Am Thorac Soc. 2018. PMID: 29787309 Free PMC article.
-
Development and Validation of a Machine Learning COVID-19 Veteran (COVet) Deterioration Risk Score.Crit Care Explor. 2024 Jul 19;6(7):e1116. doi: 10.1097/CCE.0000000000001116. eCollection 2024 Jul 1. Crit Care Explor. 2024. PMID: 39028867 Free PMC article.
-
Comparison of Early Warning Scoring Systems for Hospitalized Patients With and Without Infection at Risk for In-Hospital Mortality and Transfer to the Intensive Care Unit.JAMA Netw Open. 2020 May 1;3(5):e205191. doi: 10.1001/jamanetworkopen.2020.5191. JAMA Netw Open. 2020. PMID: 32427324 Free PMC article.
References
-
- O’Neill J: Review on Antimicrobial Resistance: Tackling Drug-Resistant Infections Globally. Wellcome Trust and the Department of Health of UK Government. 2016. Available at: https://amr-review.org/. Accessed April 15, 2024
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources